Why the study?
This study aimed to assess the impact of coronary artery bypass grafting on outcomes in elderly patients compared to younger patients.
Does coronary artery bypass grafting (CABG) have comparable early and 6-month outcomes in older adults (≥75 years) compared to younger adults (<75 years)?
Does coronary artery bypass grafting (CABG) have comparable early and 6-month outcomes in older adults (≥75 years) compared to younger adults (<75 years)?
Answers are grounded in this paper and cite their sources.
CABG is a viable treatment option for elderly patients (≥75 years) with acceptable operative risk, showing no significant difference in in-hospital or 6-month mortality compared to younger patients.
INTRODUCTION: This study aimed to assess the impact of coronary artery bypass grafting (CABG) on outcomes in elderly patients compared to younger patients. METHOD: An observational case-control study was conducted involving 535 patients, divided into two groups: older adults (≥75 years) and younger adults (<75 years). All patients underwent CABG following a similar protocol. The primary endpoints focused on early post-procedure outcomes, including in-hospital mortality and the duration of ICU or hospital stay. Patients were followed up for six months, and secondary study endpoints included long-term mortality, left ventricular ejection fraction, re-hospitalization rates, and repeated revascularization. RESULTS: 535 patients who underwent CABG were enrolled in this study. The smoking habit was significantly higher among younger adults (38.2% vs. 12.5%, P=0.001). Hypertension was more prevalent among older adults than younger adults (75% vs. 60%, P=0.044). LDL cholesterol serum levels were higher among younger adult patients (94.9±32.5 vs. 80.9±32.9, P=0.028). In-hospital death was not significantly different between younger and older adults (2.8% vs. 5.0%, P=0.34). Mortality in the six-month follow-up was non-significantly higher in the elderly (2.1% vs. 8.1%, P=0.06).A significant proportion of patients in both groups (46.9% in younger patients vs. 40% in older ones, P=0.40) received dual antiplatelet therapy (DAPT) prior to CABG due to a recent myocardial infarction and receipt of a new stent, but without increased major bleeding in both groups. CONCLUSION: CABG should be considered a viable treatment option for elderly patients with acceptable operative risk in current clinical practice.
No takes yet. Share an insight, caveat, or question.
Roxana Sadeghi (2023) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: